279 related articles for article (PubMed ID: 24971324)
1. N-glycosylation modification of plant-derived virus-like particles: an application in vaccines.
Kim HS; Jeon JH; Lee KJ; Ko K
Biomed Res Int; 2014; 2014():249519. PubMed ID: 24971324
[TBL] [Abstract][Full Text] [Related]
2. Plant-derived virus-like particles as vaccines.
Chen Q; Lai H
Hum Vaccin Immunother; 2013 Jan; 9(1):26-49. PubMed ID: 22995837
[TBL] [Abstract][Full Text] [Related]
3. Biochemical composition of haemagglutinin-based influenza virus-like particle vaccine produced by transient expression in tobacco plants.
Le Mauff F; Mercier G; Chan P; Burel C; Vaudry D; Bardor M; Vézina LP; Couture M; Lerouge P; Landry N
Plant Biotechnol J; 2015 Jun; 13(5):717-25. PubMed ID: 25523794
[TBL] [Abstract][Full Text] [Related]
4. Plant glycans: friend or foe in vaccine development?
Bosch D; Schots A
Expert Rev Vaccines; 2010 Aug; 9(8):835-42. PubMed ID: 20673008
[TBL] [Abstract][Full Text] [Related]
5. Plant glycoengineering for designing next-generation vaccines and therapeutic proteins.
Strasser R
Biotechnol Adv; 2023 Oct; 67():108197. PubMed ID: 37315875
[TBL] [Abstract][Full Text] [Related]
6. A Roadmap for the Molecular Farming of Viral Glycoprotein Vaccines: Engineering Glycosylation and Glycosylation-Directed Folding.
Margolin E; Crispin M; Meyers A; Chapman R; Rybicki EP
Front Plant Sci; 2020; 11():609207. PubMed ID: 33343609
[TBL] [Abstract][Full Text] [Related]
7. Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity.
Hyakumura M; Walsh R; Thaysen-Andersen M; Kingston NJ; La M; Lu L; Lovrecz G; Packer NH; Locarnini S; Netter HJ
J Virol; 2015 Nov; 89(22):11312-22. PubMed ID: 26339047
[TBL] [Abstract][Full Text] [Related]
8. Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic.
López-Macías C
Hum Vaccin Immunother; 2012 Mar; 8(3):411-4. PubMed ID: 22330956
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098
[TBL] [Abstract][Full Text] [Related]
10. Virus-like particles produced in plants as potential vaccines.
Scotti N; Rybicki EP
Expert Rev Vaccines; 2013 Feb; 12(2):211-24. PubMed ID: 23414411
[TBL] [Abstract][Full Text] [Related]
11. Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro.
Hendin HE; Pillet S; Lara AN; Wu CY; Charland N; Landry N; Ward BJ
Vaccine; 2017 May; 35(19):2592-2599. PubMed ID: 28389100
[TBL] [Abstract][Full Text] [Related]
12. Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity.
Joe CCD; Chatterjee S; Lovrecz G; Adams TE; Thaysen-Andersen M; Walsh R; Locarnini SA; Smooker P; Netter HJ
Vaccine; 2020 May; 38(22):3892-3901. PubMed ID: 32284273
[TBL] [Abstract][Full Text] [Related]
13. Biosynthesis of Glycoconjugate Virus-like Particles (VLPs).
Oi KK; Kloter TA; Keys TG
Methods Mol Biol; 2021; 2183():205-215. PubMed ID: 32959246
[TBL] [Abstract][Full Text] [Related]
14. Main Strategies of Plant Expression System Glycoengineering for Producing Humanized Recombinant Pharmaceutical Proteins.
Rozov SM; Permyakova NV; Deineko EV
Biochemistry (Mosc); 2018 Mar; 83(3):215-232. PubMed ID: 29625542
[TBL] [Abstract][Full Text] [Related]
15. Dengue-2 virus-like particle (VLP) based vaccine elicits the highest titers of neutralizing antibodies when produced at reduced temperature.
Boigard H; Cimica V; Galarza JM
Vaccine; 2018 Nov; 36(50):7728-7736. PubMed ID: 30377067
[TBL] [Abstract][Full Text] [Related]
16. Plant-based vaccines: novel and low-cost possible route for Mediterranean innovative vaccination strategies.
Aboul-Ata AA; Vitti A; Nuzzaci M; El-Attar AK; Piazzolla G; Tortorella C; Harandi AM; Olson O; Wright SA; Piazzolla P
Adv Virus Res; 2014; 89():1-37. PubMed ID: 24751193
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana.
Shoji Y; Prokhnevsky A; Leffet B; Vetter N; Tottey S; Satinover S; Musiychuk K; Shamloul M; Norikane J; Jones RM; Chichester JA; Green BJ; Streatfield SJ; Yusibov V
Hum Vaccin Immunother; 2015; 11(1):118-23. PubMed ID: 25483524
[TBL] [Abstract][Full Text] [Related]
18. Use of baculovirus expression system for generation of virus-like particles: successes and challenges.
Liu F; Wu X; Li L; Liu Z; Wang Z
Protein Expr Purif; 2013 Aug; 90(2):104-16. PubMed ID: 23742819
[TBL] [Abstract][Full Text] [Related]
19. Posttranslational modification of therapeutic proteins in plants.
Gomord V; Faye L
Curr Opin Plant Biol; 2004 Apr; 7(2):171-81. PubMed ID: 15003218
[TBL] [Abstract][Full Text] [Related]
20. Glyco-engineering in plants to produce human-like N-glycan structures.
Castilho A; Steinkellner H
Biotechnol J; 2012 Sep; 7(9):1088-98. PubMed ID: 22890723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
